Petrozzi L - Search Results

1

Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.

Baldacci F, Daniele S, Piccarducci R, Giampietri L, Pietrobono D, Giorgi FS, Nicoletti V, Frosini D, Libertini P, Lo Gerfo A, Petrozzi L, Donadio E, Betti L, Trincavelli ML, Siciliano G, Ceravolo R, Tognoni G, Bonuccelli U, Martini C. Baldacci F, et al. Among authors: petrozzi l. Mol Neurobiol. 2019 Sep;56(9):6451-6459. doi: 10.1007/s12035-019-1531-4. Epub 2019 Mar 2. Mol Neurobiol. 2019. PMID: 30826968

2

Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease.

Migliore L, Testa A, Scarpato R, Pavese N, Petrozzi L, Bonuccelli U. Migliore L, et al. Among authors: petrozzi l. Hum Genet. 1997 Dec;101(3):299-305. doi: 10.1007/s004390050632. Hum Genet. 1997. PMID: 9439658

3

Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease.

Napolitano A, Del Dotto P, Petrozzi L, Dell'Agnello G, Bellini G, Gambaccini G, Bonuccelli U. Napolitano A, et al. Among authors: petrozzi l. Clin Neuropharmacol. 1999 Jan-Feb;22(1):24-9. doi: 10.1097/00002826-199901000-00005. Clin Neuropharmacol. 1999. PMID: 10047930

4

Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients.

Migliore L, Botto N, Scarpato R, Petrozzi L, Cipriani G, Bonuccelli U. Migliore L, et al. Among authors: petrozzi l. Cytogenet Cell Genet. 1999;87(1-2):41-6. doi: 10.1159/000015389. Cytogenet Cell Genet. 1999. PMID: 10640809

5

Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.

Bonuccelli U, Del Dotto P, Lucetti C, Petrozzi L, Bernardini S, Gambaccini G, Rossi G, Piccini P. Bonuccelli U, et al. Among authors: petrozzi l. Clin Neuropharmacol. 2000 Jan-Feb;23(1):28-33. doi: 10.1097/00002826-200001000-00006. Clin Neuropharmacol. 2000. PMID: 10682228 Clinical Trial.

6

Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients.

Trippi F, Botto N, Scarpato R, Petrozzi L, Bonuccelli U, Latorraca S, Sorbi S, Migliore L. Trippi F, et al. Among authors: petrozzi l. Mutagenesis. 2001 Jul;16(4):323-7. doi: 10.1093/mutage/16.4.323. Mutagenesis. 2001. PMID: 11420400

7

Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients.

Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Del Dotto P, Migliore L, Scarpato R, Bonuccelli U. Petrozzi L, et al. Neurol Sci. 2001 Feb;22(1):83-4. doi: 10.1007/s100720170058. Neurol Sci. 2001. PMID: 11487213

8

Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients.

Migliore L, Scarpato R, Coppede F, Petrozzi L, Bonuccelli U, Rodilla V. Migliore L, et al. Among authors: petrozzi l. Int J Hyg Environ Health. 2001 Oct;204(1):61-6. doi: 10.1078/1438-4639-00074. Int J Hyg Environ Health. 2001. PMID: 11725348

9

Amantadine in Huntington's disease: open-label video-blinded study.

Lucetti C, Gambaccini G, Bernardini S, Dell'Agnello G, Petrozzi L, Rossi G, Bonuccelli U. Lucetti C, et al. Among authors: petrozzi l. Neurol Sci. 2002 Sep;23 Suppl 2:S83-4. doi: 10.1007/s100720200081. Neurol Sci. 2002. PMID: 12548355 Clinical Trial.

10

Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients.

Petrozzi L, Lucetti C, Scarpato R, Gambaccini G, Trippi F, Bernardini S, Del Dotto P, Migliore L, Bonuccelli U. Petrozzi L, et al. Neurol Sci. 2002 Sep;23 Suppl 2:S97-8. doi: 10.1007/s100720200087. Neurol Sci. 2002. PMID: 12548361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page